About Biomere
Biomere is a Healthcare company based in Worcester (United States) founded in 1996. CRO specializing in animal model development. Biomere offers products and services including Gene Therapy Services, Ocular PK/PD Services, Neurology Services, Oncology Services, and Toxicology Services. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified. Its competitors include InVivo Biosystems, PsychoGenics and Alpha Genesis; 1 of its 3 listed competitors has raised funding.
Company details
Biomere was established in 1996 in Worcester, United States, as a contract research organization focused on preclinical services. Proprietary rat models, including those for Type 1 and Type 2 diabetes as well as rheumatoid arthritis, are provided. In vitro models and drug discovery support are offered in areas such as autoimmune diseases, inflammation and pain, metabolic conditions, pharmacokineticspharmacodynamics, and virology. Operations emphasize disease model customization for research needs.
- Headquarters Worcester, United States
- SectorsHealthcare
- Email••••••••
- Website biomere.com
- Social LinkedIn X
- Latest Funding Round$291.33K (USD), Grant
Jan 2017
- Investors
Products & Services of Biomere
Biomere offers a comprehensive portfolio of products and services, including Gene Therapy Services, Ocular PK/PD Services, Neurology Services, Oncology Services, and Toxicology Services.
Research services for gene therapy studies and development.
Services for ocular pharmacokinetics and pharmacodynamics analysis.
Support for neurology-related preclinical studies and models.
Toxicology and research services in oncology and cancer models.
Assessment of metabolic and toxicological effects in studies.
Development and management of pharmacology models for research.
Funding Insights of Biomere
- Total Rounds 11
- Last Round Grant — $291,334
- First Round $5.56M
(Apr 2006)
- Investors Count 1
Latest 10 of 11 funding rounds of Biomere with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2017 | $291,334 | Grant | – | – | |
| Jul 2016 | $245,994 | Grant | – | – | |
| Jul 2012 | $600,000 | Grant | – | – | |
| May 2012 | $452,431 | Grant | – | – | |
| May 2012 | $452,431 | Grant | – | – | |
| Sep 2011 | $583,195 | Grant | – | – | |
| Aug 2011 | $583,195 | Grant | – | – | |
| May 2010 | $594,141 | Grant | – | – | |
| Apr 2010 | $594,141 | Grant | – | – | |
| Feb 2009 | $5.56M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Biomere
Biomere has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Biomere
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Biomere
27 people are tracked at Biomere (13 in leadership, 14 in team).
| Name | Role | Group |
|---|---|---|
Ariana Dina | Assistant Director, Training | Leadership |
Diana D. Strano Mba, Ms, Sphr | US Director Of Human Resources | Leadership |
Mark Nedelman | Chief Executive Officer | Leadership |
Susan E. Champagne | Study Director | Leadership |
Kenneth Mullinix | U.s. Head Of Surgical Services | Leadership |
Anne Berry | Assistant Director, Talent & Development | Leadership |
Stephen Blash | Chief Operating Officer | Leadership |
Rick Hu | Financial Controller/cfo | Leadership |
Deborah Curry | Marketing Director | Leadership |
Amanda Clark | Senior Program Director, Laboratory Sciences | Leadership |
Kristina Guberski | Executive Director, U.s. Quality And Compliance | Leadership |
Mary Tolley | Director Of Facilities | Leadership |
Nicole Smith | Director, Accounting | Leadership |
Elizabeth Cusson | Quality Specialist II | Team |
Lat Dan Garrigan Jr. | Senior Research Associate | Team |
Bihua Feng | Scientist | Team |
Marcie Rohan | Senior Program Manager, U.s. NHP Operations | Team |
Chris | Senior Scientist | Team |
Valeriia Syrovatska | Scientist | Team |
Megan Romprey | Small Animal Study Coordinator | Team |
7 more people are available in the full profile.
Complete people profiles for Biomere
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Biomere
3 dated milestones of Biomere across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Biomere is founded.
- Funding First funding round of $5.6M.
- Funding Latest funding round, Grant, of $291K.
Competitors of Biomere
Biomere has 3 listed competitors in our database, 1 of them funded. They include InVivo Biosystems, PsychoGenics and Alpha Genesis.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| invivobiosystems.com | 2019 | United States | $8.16M | Animal models are supplied for in-vivo analytical services. | ||
| psychogenics.com | 1999 | Tarrytown, United States | 124 | Preclinical CRO services for CNS and orphan disorders are offered. | ||
| alphagenesisinc.com | 2003 | Yemassee, United States | 143 | Company offering primate models and services for preclinical drug discovery |
Detailed competitors of Biomere
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biomere
The website of Biomere (biomere.com) receives about 3.3K visits a month.
- Monthly visits3.3K
▲ 4.7% vs previous month
Websites whose visitors overlap most with Biomere. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| fulcrumpharma.com | 100% | 1.4K | #13,530,696 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Biomere (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biomere
Complete news archive for Biomere
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biomere
Biomere was founded in 1996 and raised its 1st funding round 10 years after it was founded.
Biomere is headquartered in Worcester, United States. It is registered at Worcester, Massachusetts, United States.
Biomere was established in 1996 in Worcester, United States, as a contract research organization focused on preclinical services. Proprietary rat models, including those for Type 1 and Type 2 diabetes as well as rheumatoid arthritis, are provided. In vitro models and drug discovery support are offered in areas such as autoimmune diseases, inflammation and pain, metabolic conditions, pharmacokineticspharmacodynamics, and virology. Operations emphasize disease model customization for research needs.
Biomere's top competitors include PsychoGenics, Alpha Genesis and InVivo Biosystems.
Biomere offers Gene Therapy Services, Ocular PK/PD Services, Neurology Services, Oncology Services, and 2 more products and services.
Biomere has 1 investor. Key investors include HHS.